Targeted therapy in gastrointestinal malignancies. - Wikidata - awgldk - TriplyDB

Targeted therapy in gastrointestinal malignancies.

Targeted therapy in gastrointestinal malignancies.

http://www.wikidata.org/entity/Q37702506

about

From conventional chemotherapy to targeted therapy: use of monoclonal antibodies (moAbs) in gastrointestinal (GI) tumors.The Clinical Significance of Occult Gastrointestinal Primary Tumours in Metastatic Cancer: A Population Retrospective Cohort Study.

P2860

Q38234000-0BF8313C-9251-4591-9914-567C67291049 Q38889302-C458D4A8-4189-453A-922E-2B400A740A13

P2860

Targeted therapy in gastrointestinal malignancies.

http://www.wikidata.org/entity/Q37702506

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Targeted therapy in gastrointestinal malignancies.

@en

Targeted therapy in gastrointestinal malignancies.

@nl

type

label

Targeted therapy in gastrointestinal malignancies.

@en

Targeted therapy in gastrointestinal malignancies.

@nl

prefLabel

Targeted therapy in gastrointestinal malignancies.

@en

Targeted therapy in gastrointestinal malignancies.

@nl

P1433

Q37702506-B3AD7FC5-3199-48DF-9B75-FA0A73001161

P1476

Q37702506-4C6EFCC4-CB77-4C45-A219-E47EA653B55C

P2093

Q37702506-1CE5F4EF-9256-464B-B5FF-54E495C6686B

Q37702506-6336EE53-260C-4AC9-90A5-8D3773EA4458

Q37702506-DDD119FF-7A29-49B5-A378-3E09506B43E4

P2860

Q37702506-023338EA-DF8D-4C96-8017-BDF8126539DC

Q37702506-03552B2F-2CD9-4F7A-A250-91984C652AA0

Q37702506-035F19A3-C05C-4457-BCDE-CB854EFFB4C4

Q37702506-08963A86-9A55-4DF6-B3CD-9CC8493C4AE4

Q37702506-0C0A9278-3B67-471C-B61B-80783EA5B78D

Q37702506-0EEE9DD4-3DB1-4EA9-B35B-D4E54367DD20

Q37702506-1059FFC4-DFD0-4411-A3EC-BAE32F91B723

Q37702506-10E293E7-CC99-4C2A-9684-7317E22756DD

Q37702506-11F8E894-7995-45DD-877F-24711E8B4C97

Q37702506-17102DE2-0421-496C-BEB4-14939D8A8A81

P304

Q37702506-BFCA825D-4A14-4A73-A202-4908CE6D37E5

P31

Q37702506-1B534A25-6462-4268-8913-16426F446147

P356

Q37702506-AC4FFFBF-DB08-4CAD-B570-15A1268767D1

P407

Q37702506-CB69BA73-34A7-4E1B-877D-7BA138FE3746

P478

Q37702506-F8306F6F-8C8D-42B7-BA6B-1B8A5099F799

P577

Q37702506-5931C3A9-67F3-49EB-BED7-52447412A144

P698

Q37702506-CFEFA3C8-9D21-4A69-B3FD-B30D012DDDFD

P932

Q37702506-AE532105-5BE0-406B-9AE8-51C392FFCA15

P356

1477-3163.127639

P1433

Journal of Carcinogenesis

P1476

Targeted therapy in gastrointestinal malignancies.

@en

P2093

Ravi Chhatrala

http://www.w3.org/2001/XMLSchema#string

Renuka Iyer

http://www.w3.org/2001/XMLSchema#string

Yasmin Thanavala

http://www.w3.org/2001/XMLSchema#string

P2860

KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours.

Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer.

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Sorafenib in advanced hepatocellular carcinoma

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study

Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial

P304

4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/1477-3163.127639

http://www.w3.org/2001/XMLSchema#string

P407

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24737952

http://www.w3.org/2001/XMLSchema#string

P932

3986534

http://www.w3.org/2001/XMLSchema#string